Panniculectomy Outcomes in Patients with End-Stage Renal Disease in Preparation for Renal Transplant

被引:8
|
作者
Mundra, Leela S. [1 ]
Rubio, Gustavo A. [2 ]
AlQattan, Husain T. [2 ]
Thaller, Seth R. [3 ]
机构
[1] Univ Miami, Leonard M Miller Sch Med, CRB 1120 NW,14th St,Room 410, Miami, FL 33136 USA
[2] Univ Miami, Leonard M Miller Sch Med, DeWitt Daughtry Family Dept Surg, Miami, FL USA
[3] Univ Miami, Leonard M Miller Sch Med, Div Plast Aesthet & Reconstruct Surg, Miami, FL USA
关键词
End-stage renal disease; Obesity; Panniculectomy; Renal transplantation; Nationwide; Inpatient sample; OBESITY; COMPLICATIONS; SURGERY; RISK; ADULTS;
D O I
10.1007/s00266-017-1043-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose End-stage renal disease (ESRD) is associated with increased cardiovascular risk factors, electrolyte imbalances, and iron deficiency anemia. These factors may increase the risk of adverse outcomes in patients undergoing panniculectomy. There is a paucity of data regarding outcomes in patients with ESRD undergoing panniculectomy. The purpose of this study is to investigate whether ESRD is associated with increased rate of complications following a panniculectomy. Method The Nationwide Inpatient Sample database (2006-2011) was used to identify patients who underwent a panniculectomy. Among this cohort, patients diagnosed with end-stage renal disease were identified. Patients excluded from the study were emergency admissions, pregnant women, patients less than 18 years old, and patients with concurrent nephrectomy or kidney transplants. Demographic factors, comorbidities, and postoperative complications were evaluated. Chi-squared and risk-adjusted multivariate logistic regression analyses were performed to determine whether end-stage renal disease was associated with increased rate of postoperative complications. Results A total of 34,779 panniculectomies were performed during the study period. Of these, 613 (1.8%) were diagnosed with ESRD. Patients with ESRD were older (mean age 58.9 vs. 49.3, p < 0.01) and more likely to have Medicare (63.5 vs. 18.4%, p < 0.01). They had higher rates of comorbidities, including diabetes, hypertension, congestive heart failure, chronic lung disease, chronic anemia, liver disease, peripheral artery disease, obesity, and coagulopathies (p < 0.01). The procedure was more likely to occur at a large, teaching hospital (p < 0.01). Postoperatively, patients with ESRD had a higher rate of death (3.3 vs. 0.2%, p < 0.01), wound complications (10.6 vs. 6.2%, p < 0.01), venous thromboembolism (4.9 vs. 0.8%, p < 0.01), blood transfusions (25.3% vs. 7.0%, p < 0.01), non-renal major medical complications (40.0% vs. 8.4%), and longer hospital stay (9.2 vs. 3.8 days, p < 0.01). Multivariate logistic regression analysis controlling for age, race, sex, hospital location/teaching hospital, payer, and all comorbidities demonstrated that ESRD was independently associated with increased venous thromboembolisms (OR 2.38, 95% CI 1.48-3.83) and non-renal major medical complications (OR 1.51, 95% CI 1.19-1.91). ESRD was not independently associated with increased rate of wound complications or transfusions. Conclusion Patients with ESRD are at increased risk of VTE and non-renal major medical complications following panniculectomy. Moreover, patients with ESRD have longer hospital stays and higher rates of mortality.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 50 条
  • [31] Tuberculosis in patients with end-stage renal disease
    Fang, HC
    Lee, PT
    Chen, CL
    Wu, MJ
    Chou, KJ
    Chung, HM
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (01) : 92 - 97
  • [32] Hypertension in end-stage renal disease patients
    Zager, P
    Nikolic, J
    Raj, DSC
    Tzamaloukas, A
    Campbell, M
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (03): : 279 - 283
  • [34] Kidney Transplant Outcomes in Incarcerated End Stage Renal Disease Patients
    Rattanavich, R.
    Hoang, T.
    Villicana, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 561 - 561
  • [35] Hepatitis in patients with end-stage renal disease
    Huang, CC
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) : S236 - S241
  • [36] Gastrointestinal and hepatic disorders in end-stage renal disease and renal transplant recipients
    Abou-Saif, A
    Lewis, JH
    ADVANCES IN RENAL REPLACEMENT THERAPY, 2000, 7 (03): : 220 - 230
  • [37] End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes
    Dai, Lu
    Golembiewska, Edyta
    Lindholm, Bengt
    Stenvinkel, Peter
    EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 : 32 - 43
  • [38] Cardiovascular disease in end-stage renal disease patients
    Collins, AJ
    Li, SL
    Ma, JZ
    Herzog, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S26 - S29
  • [39] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
  • [40] End-stage renal disease in patients with Fabry disease
    Obrador, GT
    Ojo, A
    Thadhani, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : S144 - S146